As expected, the addition of autologous Tregs suppressed the activation of tumor antigen-reactive T cells (CD3+/CFSElow/IFNγ+) in anti-CD3/anti-CD28-activated aMILs stimulated with tumor antigen-pulsed autologous BM. Here, CD28 is linked to neoplasm.